Current Concepts in Surgical Pathology 2020

Program

Download the programme in PDF
Thursday, 4 June 2020
09.00–09.30Welcome

Piotr Borkowski, MD
Quest Diagnostics

09.30–10.25Breast pathology

Esther C. Yoon, MD
MD Anderson Cancer Center

10.25–10.30Questions & answers
10.30–11.25Breast pathology

Esther C. Yoon, MD
MD Anderson Cancer Center

11.25–11.30Questions & answers
11.30–12.00Coffee break
12.00–12.55Biomarkers in breast

Zoran Gatalica, MD
Caris Life Sciences

12.55–13.00Questions & answers
13.00–13.55Bioinformatics/molecular in breast pathology

Zoran Gatalica, MD
Caris Life Sciences

13.55–14.00Questions & answers
14.00–15.00Lunch
15.00–15.40Management of advanced hormone receptor positive, HER2 negative breast cancer

Rachel M. Layman, MD
MD Anderson Cancer Center

15.40–15.45Questions & answers
15.45–16.25Current approaches in neoadjuvant endocrine therapy. Guiding decisions based on Ki67 and other biomarkers

Rachel M. Layman, MD
MD Anderson Cancer Center

16.25–16.30Questions & answers
16.30–17.25Malignant mesothelioma

Cesar A. Moran, MD
MD Anderson Cancer Center

17.25–17.30Questions & answers
Friday, 5 June 2020
09.00–09.55Molecular aspects of lung carcinoma

Ronald Przygodzki, MD
US Department of Veterans Affairs

09.55–10.00Questions & answers
10.00–10.55Biomarkers/bioinformatics lung carcinoma

Ronald Przygodzki, MD
US Department of Veterans Affairs

10.55–11.00Questions & answers
11.00–11.30Coffee break
11.30–12.25Treatment options in lung carcinoma

Don Lynn Gibbons, MD
MD Anderson Cancer Center

12.25–12.30Questions & answers
12.30–13.40Esophageal pathology diagnosis, molecular & bioinformatics

Dipen Maru, MD
MD Anderson Cancer Center

13.40–13.45Questions & answers
13.45–15.00Lunch
15.00–16.10Colorectal pathology. Diagnosis, molecular & bioinformatics

Dipen Maru, MD
MD Anderson Cancer Center

16.10–16.15Questions & answers
16.15–17.40Localized approaches to gastro-esophageal cancer: how can we individualize

Jaffer A. Ajani, MD
MD Anderson Cancer Center

17.40–17.45Questions & answers
17.45–18.25Advanced gastroesophageal cancers: progress and setbacks

Jaffer A. Ajani, MD
MD Anderson Cancer Center

18.25–18.30Questions & answers
Saturday, 6 June 2020
09.00–09.55Prostate cancer: diagnosis & grading

Piotr Borkowski, MD
Quest Diagnostics

09.55–10.00Questions & answers
10.00–10.40Utilizing digital pathology and artificial intelligence (A.I.) to advance precision diagnosis, work flow, productivity and personalized care in prostate diagnostics

Piotr Borkowski, MD
Quest Diagnostics

10.40–10.45Questions & answers
10.45–11.15Coffee break
11.15–11.55Prostate cancer: personalized care based on subtypes and phenotypes

Shi-Ming Tu, MD
MD Anderson Cancer Center

11.55–12.00Questions & answers
12.00–12.40Prostate cancer: drug developments vs therapy development

Shi-Ming Tu, MD
MD Anderson Cancer Center

12.40–12.45Questions & answers
12.45Farewell

Piotr Borkowski, MD
Quest Diagnostics

Thursday, 4 June 2020
09.00–09.30
Welcome

Piotr Borkowski, MD
Quest Diagnostics

09.30–10.25
Breast pathology

Esther C. Yoon, MD
MD Anderson Cancer Center

10.25–10.30
Questions & answers
10.30–11.25
Breast pathology

Esther C. Yoon, MD
MD Anderson Cancer Center

11.25–11.30
Questions & answers
11.30–12.00
Coffee break
12.00–12.55
Biomarkers in breast

Zoran Gatalica, MD
Caris Life Sciences

12.55–13.00
Questions & answers
13.00–13.55
Bioinformatics/molecular in breast pathology

Zoran Gatalica, MD
Caris Life Sciences

13.55–14.00
Questions & answers
14.00–15.00
Lunch
15.00–15.40
Management of advanced hormone receptor positive, HER2 negative breast cancer

Rachel M. Layman, MD
MD Anderson Cancer Center

15.40–15.45
Questions & answers
15.45–16.25
Current approaches in neoadjuvant endocrine therapy. Guiding decisions based on Ki67 and other biomarkers

Rachel M. Layman, MD
MD Anderson Cancer Center

16.25–16.30
Questions & answers
16.30–17.25
Malignant mesothelioma

Cesar A. Moran, MD
MD Anderson Cancer Center

17.25–17.30
Questions & answers
Friday, 5 June 2020
09.00–09.55
Molecular aspects of lung carcinoma

Ronald Przygodzki, MD
US Department of Veterans Affairs

09.55–10.00
Questions & answers
10.00–10.55
Biomarkers/bioinformatics lung carcinoma

Ronald Przygodzki, MD
US Department of Veterans Affairs

10.55–11.00
Questions & answers
11.00–11.30
Coffee break
11.30–12.25
Treatment options in lung carcinoma

Don Lynn Gibbons, MD
MD Anderson Cancer Center

12.25–12.30
Questions & answers
12.30–13.40
Esophageal pathology diagnosis, molecular & bioinformatics

Dipen Maru, MD
MD Anderson Cancer Center

13.40–13.45
Questions & answers
13.45–15.00
Lunch
15.00–16.10
Colorectal pathology. Diagnosis, molecular & bioinformatics

Dipen Maru, MD
MD Anderson Cancer Center

16.10–16.15
Questions & answers
16.15–17.40
Localized approaches to gastro-esophageal cancer: how can we individualize

Jaffer A. Ajani, MD
MD Anderson Cancer Center

17.40–17.45
Questions & answers
17.45–18.25
Advanced gastroesophageal cancers: progress and setbacks

Jaffer A. Ajani, MD
MD Anderson Cancer Center

18.25–18.30
Questions & answers
Saturday, 6 June 2020
09.00–09.55
Prostate cancer: diagnosis & grading

Piotr Borkowski, MD
Quest Diagnostics

09.55–10.00
Questions & answers
10.00–10.40
Utilizing digital pathology and artificial intelligence (A.I.) to advance precision diagnosis, work flow, productivity and personalized care in prostate diagnostics

Piotr Borkowski, MD
Quest Diagnostics

10.40–10.45
Questions & answers
10.45–11.15
Coffee break
11.15–11.55
Prostate cancer: personalized care based on subtypes and phenotypes

Shi-Ming Tu, MD
MD Anderson Cancer Center

11.55–12.00
Questions & answers
12.00–12.40
Prostate cancer: drug developments vs therapy development

Shi-Ming Tu, MD
MD Anderson Cancer Center

12.40–12.45
Questions & answers
12.45
Farewell

Piotr Borkowski, MD
Quest Diagnostics

Organizer:
Via Medica
Media patronage :
Via Medica
Partner:
Via Medica

Strony konferencji Grupy Via Medica wykorzystują pliki cookies. Opcje dotyczące cookies można zmienić w ustawieniach przeglądarki internetowej.
Korzystanie z niniejszej strony bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie www.wszystkoociasteczkach.pl

Copyright © 2019 Via Medica | Kariera w Grupie Via Medica